Project Grant HT94252310751

The U.S. Defense Health Agency awarded a $1,880,000 Project Grant to The Institute for Cancer Research, a non-profit subsidiary of Temple University, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project to study the SRPK1-AKT signaling axis in endometrial cancer. As a prime grantee, The Institute for Cancer Research will conduct preclinical testing and analysis to develop new approaches for cancer prevention and interception. The Institute has extensive experience delivering specialized cancer research services through federal contracts and grants, including work for the NIH, Department of Defense, and National Science Foundation. Temple University, the parent organization of The Institute for Cancer Research, has a track record of providing a range of research, training, and public service projects to the federal government across key areas like biomedical science, STEM education, and public health.